| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. | Director | Common Stock | 76,348 | $402,354 | $5.27 | 12 Aug 2024 | By Catharine A. Zabrowski Irrevocable Trust |
| ACTUATE THERAPEUTICS, INC. | Director | Non-Qualified Stock Options | 15,000 | 12 Aug 2024 | Direct | ||
| ACTUATE THERAPEUTICS, INC. | Director | Stock Options | 15,000 | 22 May 2025 | Direct | ||
| Apexigen, Inc. | Director | Stock Option (right to buy) | 0 | 23 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ACTU | ACTUATE THERAPEUTICS, INC. | 22 May 2025 | 1 | $0 | 4 | Director | 23 May 2025, 16:05 |
| ACTU | ACTUATE THERAPEUTICS, INC. | 12 Aug 2024 | 1 | $0 | 4 | Director | 14 Aug 2024, 19:30 |
| ACTU | ACTUATE THERAPEUTICS, INC. | 12 Aug 2024 | 0 | $0 | 3 | Director | 12 Aug 2024, 21:49 |
| /report/000120919123047456-zabrowksi-dan-2023-08-23 | Apexigen, Inc. | 23 Aug 2023 | 1 | $0 | 4 | Director | 25 Aug 2023, 20:42 |
| /report/000120919122051971-zabrowksi-dan-2022-09-29 | Apexigen, Inc. | 29 Sep 2022 | 1 | $0 | 4 | Director | 03 Oct 2022, 19:06 |
| /report/000120919122044856-zabrowksi-dan-2022-07-29 | Apexigen, Inc. | 29 Jul 2022 | 0 | $0 | 3 | Director | 08 Aug 2022, 17:22 |